nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR1D—meninx—malignant glioma	0.0319	0.0887	CbGeAlD
Risperidone—HTR1B—dura mater—malignant glioma	0.0304	0.0843	CbGeAlD
Risperidone—HTR1D—dura mater—malignant glioma	0.0294	0.0816	CbGeAlD
Risperidone—HTR2C—choroid plexus—malignant glioma	0.0247	0.0687	CbGeAlD
Risperidone—DRD3—telencephalic ventricle—malignant glioma	0.013	0.0362	CbGeAlD
Risperidone—HTR2A—choroid plexus—malignant glioma	0.0124	0.0345	CbGeAlD
Risperidone—DRD1—telencephalic ventricle—malignant glioma	0.00933	0.0259	CbGeAlD
Risperidone—HTR1B—telencephalic ventricle—malignant glioma	0.00756	0.021	CbGeAlD
Risperidone—HTR1D—telencephalic ventricle—malignant glioma	0.00732	0.0203	CbGeAlD
Risperidone—HTR2C—telencephalic ventricle—malignant glioma	0.00725	0.0201	CbGeAlD
Risperidone—HTR7—pons—malignant glioma	0.00709	0.0197	CbGeAlD
Risperidone—HTR2A—cerebellar cortex—malignant glioma	0.00625	0.0174	CbGeAlD
Risperidone—HTR1A—telencephalic ventricle—malignant glioma	0.0061	0.0169	CbGeAlD
Risperidone—HTR7—telencephalic ventricle—malignant glioma	0.00583	0.0162	CbGeAlD
Risperidone—DRD2—telencephalic ventricle—malignant glioma	0.00551	0.0153	CbGeAlD
Risperidone—HTR2A—pons—malignant glioma	0.00442	0.0123	CbGeAlD
Risperidone—HTR2A—vertebral column—malignant glioma	0.00439	0.0122	CbGeAlD
Risperidone—HTR1B—blood vessel—malignant glioma	0.00374	0.0104	CbGeAlD
Risperidone—HTR2A—telencephalic ventricle—malignant glioma	0.00364	0.0101	CbGeAlD
Risperidone—HTR1D—blood vessel—malignant glioma	0.00362	0.0101	CbGeAlD
Risperidone—HTR2A—pineal body—malignant glioma	0.00316	0.00876	CbGeAlD
Risperidone—HTR7—endothelium—malignant glioma	0.00313	0.00869	CbGeAlD
Risperidone—HTR7—blood vessel—malignant glioma	0.00289	0.00802	CbGeAlD
Risperidone—H1F0—embryo—malignant glioma	0.00279	0.00775	CbGeAlD
Risperidone—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00262	0.00633	CcSEcCtD
Risperidone—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00258	0.00623	CcSEcCtD
Risperidone—Necrosis—Carmustine—malignant glioma	0.00256	0.00618	CcSEcCtD
Risperidone—Abscess—Carmustine—malignant glioma	0.00254	0.00613	CcSEcCtD
Risperidone—DRD1—brainstem—malignant glioma	0.00253	0.00701	CbGeAlD
Risperidone—Otitis media—Temozolomide—malignant glioma	0.0025	0.00602	CcSEcCtD
Risperidone—Coagulopathy—Temozolomide—malignant glioma	0.0025	0.00602	CcSEcCtD
Risperidone—H1F0—retina—malignant glioma	0.00247	0.00685	CbGeAlD
Risperidone—Injection site pain—Carmustine—malignant glioma	0.00246	0.00594	CcSEcCtD
Risperidone—Rigors—Temozolomide—malignant glioma	0.00238	0.00574	CcSEcCtD
Risperidone—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00236	0.0057	CcSEcCtD
Risperidone—Endocrine disorder—Temozolomide—malignant glioma	0.00234	0.00566	CcSEcCtD
Risperidone—Speech disorder—Carmustine—malignant glioma	0.00234	0.00564	CcSEcCtD
Risperidone—Liver injury—Temozolomide—malignant glioma	0.00231	0.00557	CcSEcCtD
Risperidone—H1F0—telencephalon—malignant glioma	0.00227	0.0063	CbGeAlD
Risperidone—Speech disorder—Temozolomide—malignant glioma	0.00226	0.00545	CcSEcCtD
Risperidone—Disturbance in attention—Temozolomide—malignant glioma	0.00224	0.00541	CcSEcCtD
Risperidone—DRD1—telencephalon—malignant glioma	0.00224	0.00622	CbGeAlD
Risperidone—Breast pain—Temozolomide—malignant glioma	0.00223	0.00537	CcSEcCtD
Risperidone—Amenorrhoea—Temozolomide—malignant glioma	0.00221	0.00534	CcSEcCtD
Risperidone—Thinking abnormal—Carmustine—malignant glioma	0.0022	0.0053	CcSEcCtD
Risperidone—Viral infection—Temozolomide—malignant glioma	0.00215	0.00519	CcSEcCtD
Risperidone—Leukocytosis—Carmustine—malignant glioma	0.00214	0.00516	CcSEcCtD
Risperidone—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00214	0.00516	CcSEcCtD
Risperidone—Gait disturbance—Carmustine—malignant glioma	0.00206	0.00497	CcSEcCtD
Risperidone—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00205	0.00496	CcSEcCtD
Risperidone—Coordination abnormal—Carmustine—malignant glioma	0.00205	0.00494	CcSEcCtD
Risperidone—HTR1B—brainstem—malignant glioma	0.00205	0.00568	CbGeAlD
Risperidone—Hearing impaired—Temozolomide—malignant glioma	0.00204	0.00493	CcSEcCtD
Risperidone—Neck pain—Carmustine—malignant glioma	0.00203	0.00491	CcSEcCtD
Risperidone—Pulmonary embolism—Carmustine—malignant glioma	0.00201	0.00485	CcSEcCtD
Risperidone—DRD4—brain—malignant glioma	0.00201	0.00558	CbGeAlD
Risperidone—Injection site reaction—Carmustine—malignant glioma	0.002	0.00482	CcSEcCtD
Risperidone—Gait disturbance—Temozolomide—malignant glioma	0.00199	0.0048	CcSEcCtD
Risperidone—HTR1D—brainstem—malignant glioma	0.00198	0.0055	CbGeAlD
Risperidone—Coordination abnormal—Temozolomide—malignant glioma	0.00198	0.00477	CcSEcCtD
Risperidone—Musculoskeletal pain—Temozolomide—malignant glioma	0.00197	0.00475	CcSEcCtD
Risperidone—HTR2C—brainstem—malignant glioma	0.00196	0.00545	CbGeAlD
Risperidone—HTR2A—endothelium—malignant glioma	0.00195	0.00542	CbGeAlD
Risperidone—Vaginal inflammation—Temozolomide—malignant glioma	0.00194	0.00469	CcSEcCtD
Risperidone—Pulmonary embolism—Temozolomide—malignant glioma	0.00194	0.00469	CcSEcCtD
Risperidone—Depressed level of consciousness—Carmustine—malignant glioma	0.00194	0.00468	CcSEcCtD
Risperidone—Urinary incontinence—Carmustine—malignant glioma	0.00194	0.00468	CcSEcCtD
Risperidone—Skin exfoliation—Carmustine—malignant glioma	0.00192	0.00463	CcSEcCtD
Risperidone—Influenza like illness—Temozolomide—malignant glioma	0.00189	0.00455	CcSEcCtD
Risperidone—Urinary incontinence—Temozolomide—malignant glioma	0.00188	0.00453	CcSEcCtD
Risperidone—Depressed level of consciousness—Temozolomide—malignant glioma	0.00188	0.00453	CcSEcCtD
Risperidone—Skin exfoliation—Temozolomide—malignant glioma	0.00185	0.00448	CcSEcCtD
Risperidone—Coma—Carmustine—malignant glioma	0.00184	0.00443	CcSEcCtD
Risperidone—Vaginal infection—Temozolomide—malignant glioma	0.00183	0.00443	CcSEcCtD
Risperidone—Neoplasm—Carmustine—malignant glioma	0.00182	0.00439	CcSEcCtD
Risperidone—HTR1B—telencephalon—malignant glioma	0.00182	0.00504	CbGeAlD
Risperidone—HTR2A—blood vessel—malignant glioma	0.0018	0.005	CbGeAlD
Risperidone—Gynaecomastia—Carmustine—malignant glioma	0.0018	0.00434	CcSEcCtD
Risperidone—Dry eye—Temozolomide—malignant glioma	0.00179	0.00433	CcSEcCtD
Risperidone—H1F0—medulla oblongata—malignant glioma	0.00178	0.00495	CbGeAlD
Risperidone—DRD3—central nervous system—malignant glioma	0.00178	0.00494	CbGeAlD
Risperidone—HTR1D—telencephalon—malignant glioma	0.00176	0.00488	CbGeAlD
Risperidone—Neoplasm—Temozolomide—malignant glioma	0.00176	0.00424	CcSEcCtD
Risperidone—Abnormal vision—Carmustine—malignant glioma	0.00175	0.00423	CcSEcCtD
Risperidone—Sepsis—Carmustine—malignant glioma	0.00174	0.00421	CcSEcCtD
Risperidone—Mental disability—Carmustine—malignant glioma	0.00174	0.00421	CcSEcCtD
Risperidone—HTR2C—telencephalon—malignant glioma	0.00174	0.00483	CbGeAlD
Risperidone—Abnormal vision—Temozolomide—malignant glioma	0.00169	0.00409	CcSEcCtD
Risperidone—Phlebitis—Carmustine—malignant glioma	0.00169	0.00409	CcSEcCtD
Risperidone—Mental disability—Temozolomide—malignant glioma	0.00169	0.00407	CcSEcCtD
Risperidone—Thrombophlebitis—Carmustine—malignant glioma	0.00169	0.00407	CcSEcCtD
Risperidone—Diabetes mellitus—Carmustine—malignant glioma	0.00168	0.00405	CcSEcCtD
Risperidone—Swelling—Carmustine—malignant glioma	0.00165	0.00399	CcSEcCtD
Risperidone—Ear pain—Temozolomide—malignant glioma	0.00165	0.00399	CcSEcCtD
Risperidone—HTR1A—brainstem—malignant glioma	0.00165	0.00458	CbGeAlD
Risperidone—HTR2B—telencephalon—malignant glioma	0.00164	0.00454	CbGeAlD
Risperidone—H1F0—midbrain—malignant glioma	0.00163	0.00453	CbGeAlD
Risperidone—Thrombophlebitis—Temozolomide—malignant glioma	0.00163	0.00393	CcSEcCtD
Risperidone—Eye pain—Carmustine—malignant glioma	0.00162	0.0039	CcSEcCtD
Risperidone—DRD1—midbrain—malignant glioma	0.00161	0.00447	CbGeAlD
Risperidone—Gastroenteritis—Temozolomide—malignant glioma	0.00159	0.00384	CcSEcCtD
Risperidone—H1F0—spinal cord—malignant glioma	0.00159	0.00441	CbGeAlD
Risperidone—HTR7—brainstem—malignant glioma	0.00158	0.00438	CbGeAlD
Risperidone—Vascular purpura—Temozolomide—malignant glioma	0.00158	0.0038	CcSEcCtD
Risperidone—Deafness—Temozolomide—malignant glioma	0.00158	0.0038	CcSEcCtD
Risperidone—Hepatic failure—Temozolomide—malignant glioma	0.00157	0.00379	CcSEcCtD
Risperidone—Eye pain—Temozolomide—malignant glioma	0.00156	0.00377	CcSEcCtD
Risperidone—Amnesia—Carmustine—malignant glioma	0.00155	0.00375	CcSEcCtD
Risperidone—Nasal congestion—Temozolomide—malignant glioma	0.00155	0.00374	CcSEcCtD
Risperidone—ADRA1A—brainstem—malignant glioma	0.00152	0.00423	CbGeAlD
Risperidone—Amnesia—Temozolomide—malignant glioma	0.0015	0.00362	CcSEcCtD
Risperidone—DRD2—brainstem—malignant glioma	0.00149	0.00414	CbGeAlD
Risperidone—Thirst—Temozolomide—malignant glioma	0.00148	0.00358	CcSEcCtD
Risperidone—HTR1A—telencephalon—malignant glioma	0.00147	0.00407	CbGeAlD
Risperidone—Hyponatraemia—Carmustine—malignant glioma	0.00147	0.00354	CcSEcCtD
Risperidone—Purpura—Temozolomide—malignant glioma	0.00146	0.00353	CcSEcCtD
Risperidone—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00146	0.00352	CcSEcCtD
Risperidone—Diplopia—Carmustine—malignant glioma	0.00146	0.00352	CcSEcCtD
Risperidone—DRD2—retina—malignant glioma	0.00144	0.004	CbGeAlD
Risperidone—DRD3—brain—malignant glioma	0.00141	0.00392	CbGeAlD
Risperidone—Diplopia—Temozolomide—malignant glioma	0.00141	0.0034	CcSEcCtD
Risperidone—Face oedema—Carmustine—malignant glioma	0.00141	0.0034	CcSEcCtD
Risperidone—HTR7—telencephalon—malignant glioma	0.0014	0.00389	CbGeAlD
Risperidone—Affect lability—Temozolomide—malignant glioma	0.00139	0.00335	CcSEcCtD
Risperidone—Ataxia—Carmustine—malignant glioma	0.00137	0.00331	CcSEcCtD
Risperidone—HTR2C—medulla oblongata—malignant glioma	0.00137	0.0038	CbGeAlD
Risperidone—ADRA1B—central nervous system—malignant glioma	0.00137	0.00379	CbGeAlD
Risperidone—Face oedema—Temozolomide—malignant glioma	0.00136	0.00329	CcSEcCtD
Risperidone—ADRA1A—telencephalon—malignant glioma	0.00135	0.00375	CbGeAlD
Risperidone—Mood swings—Temozolomide—malignant glioma	0.00134	0.00322	CcSEcCtD
Risperidone—Hypokalaemia—Carmustine—malignant glioma	0.00133	0.00321	CcSEcCtD
Risperidone—Ataxia—Temozolomide—malignant glioma	0.00133	0.0032	CcSEcCtD
Risperidone—DRD2—telencephalon—malignant glioma	0.00132	0.00368	CbGeAlD
Risperidone—Dehydration—Temozolomide—malignant glioma	0.00131	0.00316	CcSEcCtD
Risperidone—KCNH2—telencephalon—malignant glioma	0.0013	0.00362	CbGeAlD
Risperidone—HTR1B—midbrain—malignant glioma	0.0013	0.00362	CbGeAlD
Risperidone—Dry skin—Temozolomide—malignant glioma	0.00129	0.00312	CcSEcCtD
Risperidone—H1F0—central nervous system—malignant glioma	0.00129	0.00358	CbGeAlD
Risperidone—Muscular weakness—Carmustine—malignant glioma	0.00129	0.00311	CcSEcCtD
Risperidone—ADRA2C—telencephalon—malignant glioma	0.00129	0.00357	CbGeAlD
Risperidone—Hypokalaemia—Temozolomide—malignant glioma	0.00128	0.0031	CcSEcCtD
Risperidone—Breast disorder—Temozolomide—malignant glioma	0.00127	0.00308	CcSEcCtD
Risperidone—DRD1—central nervous system—malignant glioma	0.00127	0.00354	CbGeAlD
Risperidone—HTR1B—spinal cord—malignant glioma	0.00127	0.00353	CbGeAlD
Risperidone—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00127	0.00306	CcSEcCtD
Risperidone—HTR1D—midbrain—malignant glioma	0.00126	0.00351	CbGeAlD
Risperidone—Dysphagia—Carmustine—malignant glioma	0.00126	0.00304	CcSEcCtD
Risperidone—H1F0—cerebellum—malignant glioma	0.00126	0.0035	CbGeAlD
Risperidone—HTR2C—midbrain—malignant glioma	0.00125	0.00347	CbGeAlD
Risperidone—Muscular weakness—Temozolomide—malignant glioma	0.00124	0.003	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00124	0.003	CcSEcCtD
Risperidone—Abdominal distension—Temozolomide—malignant glioma	0.00123	0.00296	CcSEcCtD
Risperidone—HTR2C—spinal cord—malignant glioma	0.00122	0.00339	CbGeAlD
Risperidone—Dysphagia—Temozolomide—malignant glioma	0.00122	0.00294	CcSEcCtD
Risperidone—Sweating increased—Temozolomide—malignant glioma	0.00119	0.00287	CcSEcCtD
Risperidone—ABCB1—blood vessel—malignant glioma	0.00118	0.00328	CbGeAlD
Risperidone—Neutropenia—Carmustine—malignant glioma	0.00118	0.00285	CcSEcCtD
Risperidone—Bronchitis—Temozolomide—malignant glioma	0.00117	0.00283	CcSEcCtD
Risperidone—Dysuria—Temozolomide—malignant glioma	0.00114	0.00275	CcSEcCtD
Risperidone—Neutropenia—Temozolomide—malignant glioma	0.00114	0.00275	CcSEcCtD
Risperidone—Hyperglycaemia—Carmustine—malignant glioma	0.00114	0.00275	CcSEcCtD
Risperidone—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00113	0.00273	CcSEcCtD
Risperidone—Pneumonia—Carmustine—malignant glioma	0.00113	0.00273	CcSEcCtD
Risperidone—Pollakiuria—Temozolomide—malignant glioma	0.00113	0.00272	CcSEcCtD
Risperidone—Erectile dysfunction—Temozolomide—malignant glioma	0.00112	0.00271	CcSEcCtD
Risperidone—Depression—Carmustine—malignant glioma	0.00112	0.00271	CcSEcCtD
Risperidone—Photosensitivity reaction—Temozolomide—malignant glioma	0.00111	0.00268	CcSEcCtD
Risperidone—Weight increased—Temozolomide—malignant glioma	0.00111	0.00268	CcSEcCtD
Risperidone—Renal failure—Carmustine—malignant glioma	0.00111	0.00267	CcSEcCtD
Risperidone—Weight decreased—Temozolomide—malignant glioma	0.0011	0.00266	CcSEcCtD
Risperidone—Neuropathy peripheral—Carmustine—malignant glioma	0.0011	0.00266	CcSEcCtD
Risperidone—HTR7—medulla oblongata—malignant glioma	0.0011	0.00306	CbGeAlD
Risperidone—Hyperglycaemia—Temozolomide—malignant glioma	0.0011	0.00265	CcSEcCtD
Risperidone—Stomatitis—Carmustine—malignant glioma	0.0011	0.00265	CcSEcCtD
Risperidone—Urinary tract infection—Carmustine—malignant glioma	0.00109	0.00264	CcSEcCtD
Risperidone—Pneumonia—Temozolomide—malignant glioma	0.00109	0.00264	CcSEcCtD
Risperidone—Infestation NOS—Temozolomide—malignant glioma	0.00109	0.00262	CcSEcCtD
Risperidone—Infestation—Temozolomide—malignant glioma	0.00109	0.00262	CcSEcCtD
Risperidone—ADRA1B—brain—malignant glioma	0.00108	0.00301	CbGeAlD
Risperidone—Depression—Temozolomide—malignant glioma	0.00108	0.00262	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00108	0.0026	CcSEcCtD
Risperidone—HTR2A—embryo—malignant glioma	0.00107	0.00298	CbGeAlD
Risperidone—Neuropathy peripheral—Temozolomide—malignant glioma	0.00107	0.00257	CcSEcCtD
Risperidone—Stomatitis—Temozolomide—malignant glioma	0.00106	0.00256	CcSEcCtD
Risperidone—Urinary tract infection—Temozolomide—malignant glioma	0.00106	0.00255	CcSEcCtD
Risperidone—HTR1A—midbrain—malignant glioma	0.00105	0.00292	CbGeAlD
Risperidone—HRH1—telencephalon—malignant glioma	0.00105	0.0029	CbGeAlD
Risperidone—HTR1B—central nervous system—malignant glioma	0.00103	0.00287	CbGeAlD
Risperidone—Hepatobiliary disease—Temozolomide—malignant glioma	0.00103	0.00248	CcSEcCtD
Risperidone—ADRA2A—telencephalon—malignant glioma	0.00103	0.00285	CbGeAlD
Risperidone—HTR1A—spinal cord—malignant glioma	0.00103	0.00285	CbGeAlD
Risperidone—KCNH2—medulla oblongata—malignant glioma	0.00103	0.00285	CbGeAlD
Risperidone—H1F0—brain—malignant glioma	0.00102	0.00284	CbGeAlD
Risperidone—Sinusitis—Temozolomide—malignant glioma	0.00102	0.00246	CcSEcCtD
Risperidone—Haemoglobin—Carmustine—malignant glioma	0.00101	0.00245	CcSEcCtD
Risperidone—ADRA2C—medulla oblongata—malignant glioma	0.00101	0.00281	CbGeAlD
Risperidone—DRD1—brain—malignant glioma	0.00101	0.00281	CbGeAlD
Risperidone—Haemorrhage—Carmustine—malignant glioma	0.00101	0.00244	CcSEcCtD
Risperidone—HTR7—midbrain—malignant glioma	0.00101	0.00279	CbGeAlD
Risperidone—Hypoaesthesia—Carmustine—malignant glioma	0.001	0.00242	CcSEcCtD
Risperidone—HTR1D—central nervous system—malignant glioma	0.000999	0.00277	CbGeAlD
Risperidone—Oedema peripheral—Carmustine—malignant glioma	0.000995	0.0024	CcSEcCtD
Risperidone—Connective tissue disorder—Carmustine—malignant glioma	0.000992	0.00239	CcSEcCtD
Risperidone—HTR2C—central nervous system—malignant glioma	0.000989	0.00275	CbGeAlD
Risperidone—HTR2A—brainstem—malignant glioma	0.000984	0.00273	CbGeAlD
Risperidone—HTR7—spinal cord—malignant glioma	0.000981	0.00272	CbGeAlD
Risperidone—Haemoglobin—Temozolomide—malignant glioma	0.000981	0.00237	CcSEcCtD
Risperidone—Hepatitis—Temozolomide—malignant glioma	0.000976	0.00235	CcSEcCtD
Risperidone—Haemorrhage—Temozolomide—malignant glioma	0.000976	0.00235	CcSEcCtD
Risperidone—Visual impairment—Carmustine—malignant glioma	0.000973	0.00235	CcSEcCtD
Risperidone—Hypoaesthesia—Temozolomide—malignant glioma	0.000971	0.00234	CcSEcCtD
Risperidone—Pharyngitis—Temozolomide—malignant glioma	0.000968	0.00234	CcSEcCtD
Risperidone—Urinary tract disorder—Temozolomide—malignant glioma	0.000964	0.00233	CcSEcCtD
Risperidone—Oedema peripheral—Temozolomide—malignant glioma	0.000961	0.00232	CcSEcCtD
Risperidone—Connective tissue disorder—Temozolomide—malignant glioma	0.000959	0.00231	CcSEcCtD
Risperidone—Urethral disorder—Temozolomide—malignant glioma	0.000956	0.00231	CcSEcCtD
Risperidone—DRD2—midbrain—malignant glioma	0.000951	0.00264	CbGeAlD
Risperidone—HTR2A—retina—malignant glioma	0.000949	0.00264	CbGeAlD
Risperidone—Eye disorder—Carmustine—malignant glioma	0.000943	0.00228	CcSEcCtD
Risperidone—Visual impairment—Temozolomide—malignant glioma	0.00094	0.00227	CcSEcCtD
Risperidone—Flushing—Carmustine—malignant glioma	0.000937	0.00226	CcSEcCtD
Risperidone—KCNH2—midbrain—malignant glioma	0.000937	0.0026	CbGeAlD
Risperidone—HTR2B—central nervous system—malignant glioma	0.00093	0.00258	CbGeAlD
Risperidone—ADRA2C—midbrain—malignant glioma	0.000924	0.00257	CbGeAlD
Risperidone—Erythema multiforme—Temozolomide—malignant glioma	0.000922	0.00223	CcSEcCtD
Risperidone—KCNH2—spinal cord—malignant glioma	0.000914	0.00254	CbGeAlD
Risperidone—Eye disorder—Temozolomide—malignant glioma	0.000912	0.0022	CcSEcCtD
Risperidone—Tinnitus—Temozolomide—malignant glioma	0.00091	0.0022	CcSEcCtD
Risperidone—Cardiac disorder—Temozolomide—malignant glioma	0.000905	0.00219	CcSEcCtD
Risperidone—Flushing—Temozolomide—malignant glioma	0.000905	0.00219	CcSEcCtD
Risperidone—Arrhythmia—Carmustine—malignant glioma	0.000902	0.00218	CcSEcCtD
Risperidone—ADRA2C—spinal cord—malignant glioma	0.000902	0.0025	CbGeAlD
Risperidone—CYP2D6—brainstem—malignant glioma	0.000896	0.00249	CbGeAlD
Risperidone—Alopecia—Carmustine—malignant glioma	0.000892	0.00215	CcSEcCtD
Risperidone—Angiopathy—Temozolomide—malignant glioma	0.000885	0.00214	CcSEcCtD
Risperidone—Mental disorder—Carmustine—malignant glioma	0.000884	0.00213	CcSEcCtD
Risperidone—Immune system disorder—Temozolomide—malignant glioma	0.000881	0.00213	CcSEcCtD
Risperidone—Mediastinal disorder—Temozolomide—malignant glioma	0.000879	0.00212	CcSEcCtD
Risperidone—Malnutrition—Carmustine—malignant glioma	0.000879	0.00212	CcSEcCtD
Risperidone—Erythema—Carmustine—malignant glioma	0.000879	0.00212	CcSEcCtD
Risperidone—Chills—Temozolomide—malignant glioma	0.000875	0.00211	CcSEcCtD
Risperidone—HTR2A—telencephalon—malignant glioma	0.000873	0.00242	CbGeAlD
Risperidone—Alopecia—Temozolomide—malignant glioma	0.000862	0.00208	CcSEcCtD
Risperidone—Mental disorder—Temozolomide—malignant glioma	0.000855	0.00206	CcSEcCtD
Risperidone—Back pain—Carmustine—malignant glioma	0.00085	0.00205	CcSEcCtD
Risperidone—Erythema—Temozolomide—malignant glioma	0.000849	0.00205	CcSEcCtD
Risperidone—Malnutrition—Temozolomide—malignant glioma	0.000849	0.00205	CcSEcCtD
Risperidone—HTR1A—central nervous system—malignant glioma	0.000833	0.00231	CbGeAlD
Risperidone—Dysgeusia—Temozolomide—malignant glioma	0.000832	0.00201	CcSEcCtD
Risperidone—Vision blurred—Carmustine—malignant glioma	0.000828	0.002	CcSEcCtD
Risperidone—Tremor—Carmustine—malignant glioma	0.000823	0.00199	CcSEcCtD
Risperidone—Back pain—Temozolomide—malignant glioma	0.000822	0.00198	CcSEcCtD
Risperidone—HTR1B—brain—malignant glioma	0.000819	0.00228	CbGeAlD
Risperidone—HTR1A—cerebellum—malignant glioma	0.000814	0.00226	CbGeAlD
Risperidone—Anaemia—Carmustine—malignant glioma	0.000812	0.00196	CcSEcCtD
Risperidone—Agitation—Carmustine—malignant glioma	0.000808	0.00195	CcSEcCtD
Risperidone—ADRA2A—medulla oblongata—malignant glioma	0.000807	0.00224	CbGeAlD
Risperidone—Vision blurred—Temozolomide—malignant glioma	0.0008	0.00193	CcSEcCtD
Risperidone—HTR7—central nervous system—malignant glioma	0.000796	0.00221	CbGeAlD
Risperidone—Tremor—Temozolomide—malignant glioma	0.000796	0.00192	CcSEcCtD
Risperidone—CYP2D6—telencephalon—malignant glioma	0.000796	0.00221	CbGeAlD
Risperidone—HTR1D—brain—malignant glioma	0.000793	0.0022	CbGeAlD
Risperidone—Ill-defined disorder—Temozolomide—malignant glioma	0.000788	0.0019	CcSEcCtD
Risperidone—Leukopenia—Carmustine—malignant glioma	0.000787	0.0019	CcSEcCtD
Risperidone—HTR2C—brain—malignant glioma	0.000786	0.00218	CbGeAlD
Risperidone—Anaemia—Temozolomide—malignant glioma	0.000785	0.00189	CcSEcCtD
Risperidone—Agitation—Temozolomide—malignant glioma	0.00078	0.00188	CcSEcCtD
Risperidone—HTR7—cerebellum—malignant glioma	0.000778	0.00216	CbGeAlD
Risperidone—Angioedema—Temozolomide—malignant glioma	0.000776	0.00187	CcSEcCtD
Risperidone—ADRA1A—central nervous system—malignant glioma	0.000768	0.00213	CbGeAlD
Risperidone—Malaise—Temozolomide—malignant glioma	0.000766	0.00185	CcSEcCtD
Risperidone—Vertigo—Temozolomide—malignant glioma	0.000763	0.00184	CcSEcCtD
Risperidone—Convulsion—Carmustine—malignant glioma	0.000761	0.00184	CcSEcCtD
Risperidone—Leukopenia—Temozolomide—malignant glioma	0.00076	0.00183	CcSEcCtD
Risperidone—Hypertension—Carmustine—malignant glioma	0.000759	0.00183	CcSEcCtD
Risperidone—DRD2—central nervous system—malignant glioma	0.000753	0.00209	CbGeAlD
Risperidone—Palpitations—Temozolomide—malignant glioma	0.000751	0.00181	CcSEcCtD
Risperidone—ADRA1A—cerebellum—malignant glioma	0.00075	0.00208	CbGeAlD
Risperidone—Myalgia—Carmustine—malignant glioma	0.000748	0.00181	CcSEcCtD
Risperidone—Chest pain—Carmustine—malignant glioma	0.000748	0.00181	CcSEcCtD
Risperidone—Anxiety—Carmustine—malignant glioma	0.000746	0.0018	CcSEcCtD
Risperidone—KCNH2—central nervous system—malignant glioma	0.000741	0.00206	CbGeAlD
Risperidone—Cough—Temozolomide—malignant glioma	0.000741	0.00179	CcSEcCtD
Risperidone—HTR2B—brain—malignant glioma	0.000738	0.00205	CbGeAlD
Risperidone—ADRA2A—midbrain—malignant glioma	0.000738	0.00205	CbGeAlD
Risperidone—Convulsion—Temozolomide—malignant glioma	0.000736	0.00178	CcSEcCtD
Risperidone—DRD2—cerebellum—malignant glioma	0.000736	0.00204	CbGeAlD
Risperidone—Hypertension—Temozolomide—malignant glioma	0.000733	0.00177	CcSEcCtD
Risperidone—ADRA2C—central nervous system—malignant glioma	0.000732	0.00203	CbGeAlD
Risperidone—KCNH2—cerebellum—malignant glioma	0.000725	0.00201	CbGeAlD
Risperidone—Confusional state—Carmustine—malignant glioma	0.000723	0.00175	CcSEcCtD
Risperidone—Arthralgia—Temozolomide—malignant glioma	0.000723	0.00174	CcSEcCtD
Risperidone—Myalgia—Temozolomide—malignant glioma	0.000723	0.00174	CcSEcCtD
Risperidone—Anxiety—Temozolomide—malignant glioma	0.000721	0.00174	CcSEcCtD
Risperidone—ADRA2A—spinal cord—malignant glioma	0.00072	0.002	CbGeAlD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000718	0.00173	CcSEcCtD
Risperidone—Oedema—Carmustine—malignant glioma	0.000717	0.00173	CcSEcCtD
Risperidone—ADRA2C—cerebellum—malignant glioma	0.000715	0.00199	CbGeAlD
Risperidone—Discomfort—Temozolomide—malignant glioma	0.000714	0.00172	CcSEcCtD
Risperidone—Infection—Carmustine—malignant glioma	0.000713	0.00172	CcSEcCtD
Risperidone—Dry mouth—Temozolomide—malignant glioma	0.000707	0.00171	CcSEcCtD
Risperidone—ABCB1—embryo—malignant glioma	0.000704	0.00195	CbGeAlD
Risperidone—Thrombocytopenia—Carmustine—malignant glioma	0.000702	0.00169	CcSEcCtD
Risperidone—Tachycardia—Carmustine—malignant glioma	0.0007	0.00169	CcSEcCtD
Risperidone—Confusional state—Temozolomide—malignant glioma	0.000699	0.00169	CcSEcCtD
Risperidone—Oedema—Temozolomide—malignant glioma	0.000693	0.00167	CcSEcCtD
Risperidone—Anaphylactic shock—Temozolomide—malignant glioma	0.000693	0.00167	CcSEcCtD
Risperidone—Infection—Temozolomide—malignant glioma	0.000689	0.00166	CcSEcCtD
Risperidone—HTR2A—medulla oblongata—malignant glioma	0.000686	0.00191	CbGeAlD
Risperidone—Anorexia—Carmustine—malignant glioma	0.000684	0.00165	CcSEcCtD
Risperidone—Nervous system disorder—Temozolomide—malignant glioma	0.00068	0.00164	CcSEcCtD
Risperidone—Thrombocytopenia—Temozolomide—malignant glioma	0.000679	0.00164	CcSEcCtD
Risperidone—Skin disorder—Temozolomide—malignant glioma	0.000673	0.00162	CcSEcCtD
Risperidone—Hypotension—Carmustine—malignant glioma	0.00067	0.00162	CcSEcCtD
Risperidone—Hyperhidrosis—Temozolomide—malignant glioma	0.00067	0.00162	CcSEcCtD
Risperidone—HTR1A—brain—malignant glioma	0.000661	0.00184	CbGeAlD
Risperidone—Anorexia—Temozolomide—malignant glioma	0.000661	0.00159	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000653	0.00158	CcSEcCtD
Risperidone—Insomnia—Carmustine—malignant glioma	0.000649	0.00157	CcSEcCtD
Risperidone—Paraesthesia—Carmustine—malignant glioma	0.000644	0.00155	CcSEcCtD
Risperidone—Dyspnoea—Carmustine—malignant glioma	0.000639	0.00154	CcSEcCtD
Risperidone—Somnolence—Carmustine—malignant glioma	0.000638	0.00154	CcSEcCtD
Risperidone—HTR7—brain—malignant glioma	0.000632	0.00175	CbGeAlD
Risperidone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000632	0.00152	CcSEcCtD
Risperidone—HTR2A—midbrain—malignant glioma	0.000627	0.00174	CbGeAlD
Risperidone—Insomnia—Temozolomide—malignant glioma	0.000627	0.00151	CcSEcCtD
Risperidone—Decreased appetite—Carmustine—malignant glioma	0.000624	0.0015	CcSEcCtD
Risperidone—Paraesthesia—Temozolomide—malignant glioma	0.000622	0.0015	CcSEcCtD
Risperidone—ABCB1—retina—malignant glioma	0.000622	0.00173	CbGeAlD
Risperidone—Gastrointestinal disorder—Carmustine—malignant glioma	0.000619	0.00149	CcSEcCtD
Risperidone—Dyspnoea—Temozolomide—malignant glioma	0.000618	0.00149	CcSEcCtD
Risperidone—Somnolence—Temozolomide—malignant glioma	0.000616	0.00149	CcSEcCtD
Risperidone—Constipation—Carmustine—malignant glioma	0.000613	0.00148	CcSEcCtD
Risperidone—Pain—Carmustine—malignant glioma	0.000613	0.00148	CcSEcCtD
Risperidone—HTR2A—spinal cord—malignant glioma	0.000612	0.0017	CbGeAlD
Risperidone—Dyspepsia—Temozolomide—malignant glioma	0.00061	0.00147	CcSEcCtD
Risperidone—ADRA1A—brain—malignant glioma	0.00061	0.00169	CbGeAlD
Risperidone—Decreased appetite—Temozolomide—malignant glioma	0.000603	0.00145	CcSEcCtD
Risperidone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000598	0.00144	CcSEcCtD
Risperidone—Fatigue—Temozolomide—malignant glioma	0.000598	0.00144	CcSEcCtD
Risperidone—DRD2—brain—malignant glioma	0.000597	0.00166	CbGeAlD
Risperidone—HRH1—central nervous system—malignant glioma	0.000594	0.00165	CbGeAlD
Risperidone—Pain—Temozolomide—malignant glioma	0.000593	0.00143	CcSEcCtD
Risperidone—Constipation—Temozolomide—malignant glioma	0.000593	0.00143	CcSEcCtD
Risperidone—Feeling abnormal—Carmustine—malignant glioma	0.000591	0.00143	CcSEcCtD
Risperidone—KCNH2—brain—malignant glioma	0.000589	0.00163	CbGeAlD
Risperidone—Gastrointestinal pain—Carmustine—malignant glioma	0.000587	0.00142	CcSEcCtD
Risperidone—ADRA2A—central nervous system—malignant glioma	0.000584	0.00162	CbGeAlD
Risperidone—ADRA2C—brain—malignant glioma	0.000581	0.00161	CbGeAlD
Risperidone—ABCB1—telencephalon—malignant glioma	0.000572	0.00159	CbGeAlD
Risperidone—Feeling abnormal—Temozolomide—malignant glioma	0.000571	0.00138	CcSEcCtD
Risperidone—ADRA2A—cerebellum—malignant glioma	0.000571	0.00158	CbGeAlD
Risperidone—Body temperature increased—Carmustine—malignant glioma	0.000567	0.00137	CcSEcCtD
Risperidone—Abdominal pain—Carmustine—malignant glioma	0.000567	0.00137	CcSEcCtD
Risperidone—Gastrointestinal pain—Temozolomide—malignant glioma	0.000567	0.00137	CcSEcCtD
Risperidone—Urticaria—Temozolomide—malignant glioma	0.000551	0.00133	CcSEcCtD
Risperidone—Body temperature increased—Temozolomide—malignant glioma	0.000548	0.00132	CcSEcCtD
Risperidone—Abdominal pain—Temozolomide—malignant glioma	0.000548	0.00132	CcSEcCtD
Risperidone—Hypersensitivity—Carmustine—malignant glioma	0.000528	0.00128	CcSEcCtD
Risperidone—Asthenia—Carmustine—malignant glioma	0.000515	0.00124	CcSEcCtD
Risperidone—Hypersensitivity—Temozolomide—malignant glioma	0.000511	0.00123	CcSEcCtD
Risperidone—Asthenia—Temozolomide—malignant glioma	0.000497	0.0012	CcSEcCtD
Risperidone—HTR2A—central nervous system—malignant glioma	0.000496	0.00138	CbGeAlD
Risperidone—Diarrhoea—Carmustine—malignant glioma	0.000491	0.00118	CcSEcCtD
Risperidone—Pruritus—Temozolomide—malignant glioma	0.00049	0.00118	CcSEcCtD
Risperidone—HTR2A—cerebellum—malignant glioma	0.000485	0.00135	CbGeAlD
Risperidone—Dizziness—Carmustine—malignant glioma	0.000474	0.00114	CcSEcCtD
Risperidone—Diarrhoea—Temozolomide—malignant glioma	0.000474	0.00114	CcSEcCtD
Risperidone—HRH1—brain—malignant glioma	0.000472	0.00131	CbGeAlD
Risperidone—ADRA2A—brain—malignant glioma	0.000463	0.00129	CbGeAlD
Risperidone—CYP3A4—central nervous system—malignant glioma	0.00046	0.00128	CbGeAlD
Risperidone—Dizziness—Temozolomide—malignant glioma	0.000458	0.00111	CcSEcCtD
Risperidone—Vomiting—Carmustine—malignant glioma	0.000456	0.0011	CcSEcCtD
Risperidone—Rash—Carmustine—malignant glioma	0.000452	0.00109	CcSEcCtD
Risperidone—CYP2D6—central nervous system—malignant glioma	0.000452	0.00126	CbGeAlD
Risperidone—Dermatitis—Carmustine—malignant glioma	0.000452	0.00109	CcSEcCtD
Risperidone—ABCB1—medulla oblongata—malignant glioma	0.00045	0.00125	CbGeAlD
Risperidone—Headache—Carmustine—malignant glioma	0.000449	0.00108	CcSEcCtD
Risperidone—CYP2D6—cerebellum—malignant glioma	0.000442	0.00123	CbGeAlD
Risperidone—Vomiting—Temozolomide—malignant glioma	0.000441	0.00106	CcSEcCtD
Risperidone—Rash—Temozolomide—malignant glioma	0.000437	0.00105	CcSEcCtD
Risperidone—Dermatitis—Temozolomide—malignant glioma	0.000437	0.00105	CcSEcCtD
Risperidone—Headache—Temozolomide—malignant glioma	0.000434	0.00105	CcSEcCtD
Risperidone—Nausea—Carmustine—malignant glioma	0.000426	0.00103	CcSEcCtD
Risperidone—Nausea—Temozolomide—malignant glioma	0.000412	0.000994	CcSEcCtD
Risperidone—ABCB1—midbrain—malignant glioma	0.000411	0.00114	CbGeAlD
Risperidone—ABCB1—spinal cord—malignant glioma	0.000401	0.00111	CbGeAlD
Risperidone—HTR2A—brain—malignant glioma	0.000394	0.00109	CbGeAlD
Risperidone—CYP2D6—brain—malignant glioma	0.000359	0.000997	CbGeAlD
Risperidone—ABCB1—central nervous system—malignant glioma	0.000325	0.000903	CbGeAlD
Risperidone—ABCB1—cerebellum—malignant glioma	0.000318	0.000883	CbGeAlD
Risperidone—ABCB1—brain—malignant glioma	0.000258	0.000717	CbGeAlD
Risperidone—HTR1A—Signaling Pathways—CASP3—malignant glioma	1.18e-05	5.25e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL2—malignant glioma	1.18e-05	5.24e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	1.18e-05	5.22e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CASP3—malignant glioma	1.18e-05	5.22e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL2—malignant glioma	1.18e-05	5.21e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—malignant glioma	1.17e-05	5.18e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EGFR—malignant glioma	1.17e-05	5.18e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	1.17e-05	5.17e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MDM2—malignant glioma	1.16e-05	5.15e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	1.16e-05	5.15e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MMP9—malignant glioma	1.16e-05	5.14e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RAF1—malignant glioma	1.16e-05	5.13e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—STAT3—malignant glioma	1.16e-05	5.13e-05	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	1.16e-05	5.13e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—malignant glioma	1.15e-05	5.11e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—KRAS—malignant glioma	1.15e-05	5.11e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PTEN—malignant glioma	1.15e-05	5.11e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	1.15e-05	5.1e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	1.15e-05	5.09e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP3—malignant glioma	1.15e-05	5.08e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ERBB2—malignant glioma	1.14e-05	5.08e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	1.14e-05	5.08e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—KRAS—malignant glioma	1.14e-05	5.08e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL2—malignant glioma	1.14e-05	5.07e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MDM2—malignant glioma	1.14e-05	5.07e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—STAT3—malignant glioma	1.14e-05	5.06e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MDM2—malignant glioma	1.14e-05	5.06e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MYC—malignant glioma	1.14e-05	5.05e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RAF1—malignant glioma	1.14e-05	5.05e-05	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	1.14e-05	5.05e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RAF1—malignant glioma	1.14e-05	5.04e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	1.14e-05	5.04e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CB—malignant glioma	1.13e-05	5.01e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CAV1—malignant glioma	1.13e-05	5.01e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP3—malignant glioma	1.13e-05	5e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ERBB2—malignant glioma	1.13e-05	5e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL2—malignant glioma	1.13e-05	4.99e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ERBB2—malignant glioma	1.12e-05	4.99e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	1.12e-05	4.98e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	1.12e-05	4.98e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—KRAS—malignant glioma	1.12e-05	4.97e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MDM2—malignant glioma	1.12e-05	4.96e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MMP9—malignant glioma	1.12e-05	4.96e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RAF1—malignant glioma	1.11e-05	4.94e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—malignant glioma	1.11e-05	4.94e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MMP9—malignant glioma	1.11e-05	4.93e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PTEN—malignant glioma	1.11e-05	4.93e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	1.11e-05	4.93e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—FGF2—malignant glioma	1.11e-05	4.93e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CB—malignant glioma	1.11e-05	4.92e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.11e-05	4.92e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PTEN—malignant glioma	1.11e-05	4.91e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	1.1e-05	4.89e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—KRAS—malignant glioma	1.1e-05	4.89e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—malignant glioma	1.1e-05	4.87e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CG—malignant glioma	1.09e-05	4.84e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	1.09e-05	4.83e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCL8—malignant glioma	1.09e-05	4.81e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—malignant glioma	1.08e-05	4.81e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MMP9—malignant glioma	1.08e-05	4.8e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—malignant glioma	1.08e-05	4.79e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PTEN—malignant glioma	1.08e-05	4.77e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MYC—malignant glioma	1.07e-05	4.77e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCL8—malignant glioma	1.07e-05	4.74e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCL8—malignant glioma	1.07e-05	4.73e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MMP9—malignant glioma	1.07e-05	4.72e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MYC—malignant glioma	1.06e-05	4.7e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PTEN—malignant glioma	1.06e-05	4.7e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PIK3CA—malignant glioma	1.06e-05	4.69e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARG—malignant glioma	1.05e-05	4.67e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—KRAS—malignant glioma	1.05e-05	4.67e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	1.05e-05	4.66e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—malignant glioma	1.05e-05	4.66e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	1.05e-05	4.66e-05	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—malignant glioma	1.05e-05	4.65e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.05e-05	4.64e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTEN—malignant glioma	1.05e-05	4.64e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.04e-05	4.63e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	1.04e-05	4.61e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MDM2—malignant glioma	1.04e-05	4.61e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP3—malignant glioma	1.04e-05	4.61e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL2—malignant glioma	1.04e-05	4.6e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—malignant glioma	1.04e-05	4.6e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RAF1—malignant glioma	1.04e-05	4.59e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	1.03e-05	4.58e-05	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	1.03e-05	4.58e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—STAT3—malignant glioma	1.03e-05	4.57e-05	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—malignant glioma	1.03e-05	4.57e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	1.03e-05	4.57e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.03e-05	4.56e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	1.02e-05	4.55e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—malignant glioma	1.02e-05	4.54e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—malignant glioma	1.02e-05	4.53e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL2—malignant glioma	1.02e-05	4.53e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—malignant glioma	1.02e-05	4.52e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL2—malignant glioma	1.02e-05	4.52e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—malignant glioma	1.02e-05	4.51e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PIK3CA—malignant glioma	1.01e-05	4.49e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	1.01e-05	4.49e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	1.01e-05	4.48e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1e-05	4.45e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—malignant glioma	1e-05	4.44e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL2—malignant glioma	1e-05	4.43e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—malignant glioma	9.99e-06	4.43e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—malignant glioma	9.96e-06	4.42e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—STAT3—malignant glioma	9.94e-06	4.41e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KRAS—malignant glioma	9.93e-06	4.4e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARG—malignant glioma	9.93e-06	4.4e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—STAT3—malignant glioma	9.89e-06	4.39e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTP1—malignant glioma	9.85e-06	4.37e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—malignant glioma	9.82e-06	4.36e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—malignant glioma	9.8e-06	4.35e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KRAS—malignant glioma	9.8e-06	4.34e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PTEN—malignant glioma	9.76e-06	4.33e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	9.72e-06	4.31e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	9.72e-06	4.31e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	9.67e-06	4.29e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—malignant glioma	9.66e-06	4.29e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—malignant glioma	9.64e-06	4.28e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—STAT3—malignant glioma	9.62e-06	4.27e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PTEN—malignant glioma	9.6e-06	4.26e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CD—malignant glioma	9.59e-06	4.26e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAT—malignant glioma	9.59e-06	4.25e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PTEN—malignant glioma	9.58e-06	4.25e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTEN—malignant glioma	9.58e-06	4.25e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—malignant glioma	9.57e-06	4.25e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	9.56e-06	4.24e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—malignant glioma	9.52e-06	4.22e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—STAT3—malignant glioma	9.47e-06	4.2e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—malignant glioma	9.46e-06	4.2e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PTEN—malignant glioma	9.4e-06	4.17e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	9.39e-06	4.16e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—malignant glioma	9.37e-06	4.16e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—malignant glioma	9.36e-06	4.15e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—malignant glioma	9.36e-06	4.15e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—malignant glioma	9.35e-06	4.15e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PIK3CA—malignant glioma	9.35e-06	4.15e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—malignant glioma	9.3e-06	4.13e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL2—malignant glioma	9.29e-06	4.12e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—malignant glioma	9.24e-06	4.1e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—malignant glioma	9.19e-06	4.08e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	9.18e-06	4.07e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CA—malignant glioma	9.12e-06	4.05e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CA—malignant glioma	9.08e-06	4.03e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NCOR1—malignant glioma	9.06e-06	4.02e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CD—malignant glioma	9.04e-06	4.01e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—malignant glioma	9.04e-06	4.01e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CA—malignant glioma	9e-06	3.99e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—malignant glioma	8.99e-06	3.99e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—malignant glioma	8.94e-06	3.97e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KRAS—malignant glioma	8.84e-06	3.92e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—malignant glioma	8.82e-06	3.91e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—malignant glioma	8.82e-06	3.91e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—malignant glioma	8.8e-06	3.9e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—malignant glioma	8.79e-06	3.9e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—malignant glioma	8.74e-06	3.88e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PTEN—malignant glioma	8.74e-06	3.88e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—STAT3—malignant glioma	8.73e-06	3.87e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—malignant glioma	8.71e-06	3.86e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—malignant glioma	8.68e-06	3.85e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—malignant glioma	8.66e-06	3.84e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—malignant glioma	8.65e-06	3.84e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—malignant glioma	8.61e-06	3.82e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—STAT3—malignant glioma	8.59e-06	3.81e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—malignant glioma	8.59e-06	3.81e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—STAT3—malignant glioma	8.57e-06	3.8e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KRAS—malignant glioma	8.54e-06	3.79e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	8.52e-06	3.78e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	8.49e-06	3.77e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KRAS—malignant glioma	8.49e-06	3.77e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—STAT3—malignant glioma	8.41e-06	3.73e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—malignant glioma	8.41e-06	3.73e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CB—malignant glioma	8.36e-06	3.71e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—malignant glioma	8.29e-06	3.68e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—malignant glioma	8.28e-06	3.67e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KRAS—malignant glioma	8.26e-06	3.66e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KRAS—malignant glioma	8.13e-06	3.61e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	8.12e-06	3.6e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—malignant glioma	8.11e-06	3.6e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—malignant glioma	7.98e-06	3.54e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—malignant glioma	7.96e-06	3.53e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—malignant glioma	7.93e-06	3.52e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—malignant glioma	7.9e-06	3.5e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	7.89e-06	3.5e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CB—malignant glioma	7.88e-06	3.5e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—malignant glioma	7.86e-06	3.49e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	7.84e-06	3.48e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—malignant glioma	7.82e-06	3.47e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—STAT3—malignant glioma	7.82e-06	3.47e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—malignant glioma	7.81e-06	3.46e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—malignant glioma	7.81e-06	3.46e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	7.8e-06	3.46e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—malignant glioma	7.79e-06	3.46e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—malignant glioma	7.64e-06	3.39e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—malignant glioma	7.64e-06	3.39e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	7.59e-06	3.37e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—malignant glioma	7.59e-06	3.37e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—malignant glioma	7.55e-06	3.35e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KRAS—malignant glioma	7.5e-06	3.32e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	7.47e-06	3.31e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—malignant glioma	7.45e-06	3.3e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—malignant glioma	7.41e-06	3.29e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAV1—malignant glioma	7.38e-06	3.27e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KRAS—malignant glioma	7.38e-06	3.27e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CA—malignant glioma	7.37e-06	3.27e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KRAS—malignant glioma	7.36e-06	3.26e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—malignant glioma	7.35e-06	3.26e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—malignant glioma	7.34e-06	3.26e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—malignant glioma	7.26e-06	3.22e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTEN—malignant glioma	7.23e-06	3.21e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—malignant glioma	7.23e-06	3.21e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KRAS—malignant glioma	7.22e-06	3.2e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—malignant glioma	7.1e-06	3.15e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CA—malignant glioma	6.89e-06	3.05e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTEN—malignant glioma	6.81e-06	3.02e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	6.78e-06	3.01e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CA—malignant glioma	6.76e-06	3e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CA—malignant glioma	6.76e-06	3e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.72e-06	2.98e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KRAS—malignant glioma	6.71e-06	2.98e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—malignant glioma	6.66e-06	2.95e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—malignant glioma	6.64e-06	2.94e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	6.63e-06	2.94e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—malignant glioma	6.56e-06	2.91e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—malignant glioma	6.54e-06	2.9e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARG—malignant glioma	6.49e-06	2.88e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—malignant glioma	6.42e-06	2.85e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—malignant glioma	6.41e-06	2.84e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—malignant glioma	6.37e-06	2.83e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—malignant glioma	6.2e-06	2.75e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	6.16e-06	2.73e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—malignant glioma	6.1e-06	2.71e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—malignant glioma	6.02e-06	2.67e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—malignant glioma	5.96e-06	2.65e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.91e-06	2.62e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—malignant glioma	5.63e-06	2.5e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—malignant glioma	5.54e-06	2.46e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—malignant glioma	5.52e-06	2.45e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—malignant glioma	5.52e-06	2.45e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—malignant glioma	5.42e-06	2.4e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.15e-06	2.29e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—malignant glioma	5.11e-06	2.26e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CA—malignant glioma	5.1e-06	2.26e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—malignant glioma	5.04e-06	2.23e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CA—malignant glioma	4.8e-06	2.13e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTEN—malignant glioma	4.45e-06	1.97e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—malignant glioma	4.16e-06	1.85e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—malignant glioma	3.92e-06	1.74e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.14e-06	1.39e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—malignant glioma	2.57e-06	1.14e-05	CbGpPWpGaD
